AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cardinal Health (CAH) Soars 1.51% on Morgan Stanley Price Target Hike
Generated by AI AgentAinvest Movers Radar
Friday, Jun 13, 2025 6:11 pm ET1min read
Cardinal Health (CAH) surged to a record high today, with an intraday gain of 1.51%.
The strategy of buying shares after they reached a recent high and holding for 1 week showed poor performance over the past 5 years. The annualized return was -1.7%, significantly underperforming the market. This indicates that relying solely on recent highs as a buying trigger and holding for a short duration is not a reliable strategy for CAH, leading to underwhelming returns.On June 13, 2025,
announced an increase in the price target for (CAH), which is the most relevant reason for the change in the stock price. The analyst maintained an "Overweight" rating for CAH and raised the price target from $166.00 to $181.00. This adjustment reflects a positive outlook on the company's future performance, indicating increased confidence in Cardinal Health's growth prospects and market position. This news is likely to influence investor sentiment and the stock's market trajectory.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Two Harbors (TWO) Surges 1.59% to Monthly High Amid Anticipation of $1.3B UWM Acquisition
Dec.19 2025
Trane Technologies Surges 1.46% on Q3 Earnings, Analysts Target $550
Dec.19 2025
Rivian (RIVN) Surges 27.34% on Analyst Upgrades, Q3 Revenue Growth Drives Rebound
Dec.19 2025
Tata Chemicals Share Price Soars 119.32% on Novabay Acquisition Drive
Dec.19 2025
X3 Holdings (XTKG) Rallies 36.76% Intraday, 22.50% in Three Sessions on Technical Rebound and Speculative Buying
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet